We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Portable Device Detects Rare Genetic Mutations from Single Drop of Blood

By LabMedica International staff writers
Posted on 11 Jun 2025

Current genetic testing methods often take days or even weeks to detect rare mutations, delaying timely diagnosis and treatment, especially for conditions like hereditary transthyretin amyloidosis, which can lead to heart failure in people of West African ancestry. More...

To address this urgent need for faster, accessible diagnostics, researchers have developed a portable device capable of detecting specific genetic mutations from just one drop of blood, delivering accurate results in under 10 minutes.

The innovation comes from a team led by engineers at Rutgers University-New Brunswick (New Brunswick, NJ, USA) and Yale University (New Haven, CT, USA), and is detailed in a new study published in Communications Engineering. The goal was to bring the lab-level accuracy of a traditional polymerase chain reaction (PCR) test to point-of-care environments, including doctors' offices, homes, and community centers. The device functions by combining a specialized version of PCR—called allele-specific polymerase chain reaction (ASPCR)—with a technology known as electrical impedance. It amplifies nucleic acid segments and uses a microchip to detect whether specific mutations are present. Electrical impedance measures how the DNA samples influence the flow of electricity within microfluidic chips, which are engineered to detect tiny variations in DNA or RNA sequences from blood samples. While standard PCR amplifies DNA broadly, ASPCR is designed specifically to detect point mutations—single-base changes in the DNA sequence that can lead to diseases such as sickle cell anemia, hemophilia, and certain cancers.

In lab testing, the team evaluated the device using blood samples from six patients and successfully identified whether or not they carried the transthyretin gene mutation. These early tests demonstrated both speed and accuracy, with the added benefit of portability, making it suitable for use outside traditional lab settings. ASPCR can be tailored to detect many specific genetic mutations tied to diseases. In addition, microfluidic chips can be designed to detect different types of DNA or RNA sequences, giving them great potential for detecting various diseases. The researchers are now working to enhance the sensitivity and specificity of the system.

Future iterations aim to detect up to 20 different point mutations in a single test, creating a broad-spectrum diagnostic platform. The adaptability of ASPCR and the customizability of microfluidic chips offer the potential to screen for a wide range of genetic disorders with a single drop of blood. Currently, the ASPCR analysis—which enables the amplification of DNA mutations directly from a small blood sample—is performed externally, outside the microfluidic microchip. Once this step is complete, the resulting amplified DNA is then detected by the microchip. The ultimate objective is to integrate both the ASPCR process and the electrical detection onto a single microchip platform.

“What we've figured out is how to make a device that has the potential to bring a kind of PCR testing, particularly in the context of detecting rare mutations, home, like a glucometer,” said Mehdi Javanmard, an author of the study. “This technique holds great promise for detecting a variety of diseases, thanks to its versatility, speed and potential for cost-effective and portable diagnostics.”

 


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.